Here is Why Absci Corp. (ABSI) is One of the Best Biotech Penny Stocks to Buy in 2026

Absci Corporation (NASDAQ:ABSI) is one of the best biotech penny stocks to buy in 2026. On March 24, Absci reported Q4 and the full-year 2025 financial results, highlighting significant progress in its internal pipeline of AI-designed therapeutics. The company dosed the first three cohorts in its HEADLINE Phase 1/2a trial for ABS-201, a novel anti-PRLR antibody targeting androgenetic alopecia. Emerging data indicates the treatment is well-tolerated, and recent ex vivo studies suggest ABS-201 can stimulate hair growth by regenerating the follicle stem cell niche.

Absci expects to release preliminary safety and pharmacokinetic data in H1 2026, followed by interim proof-of-concept results in H2. The company is also diversifying the application of ABS-201 by preparing to initiate a Phase 2 trial for endometriosis in the fourth quarter of 2026. This expansion targets a significant unmet need for non-sex steroid hormone treatments in a market affecting millions of women.

Here is Why Absci Corp. (ABSI) is One of the Best Biotech Penny Stocks to Buy in 2026

Financially, Absci reported a full-year net loss of $115.2 million for 2025, with R&D expenses rising to $81.4 million as internal programs moved toward the clinic. Despite the increase in spending, the company maintains a solid balance sheet with $144.3 million in cash, cash equivalents, and marketable securities as of December 31. Management noted that this capital is sufficient to fund operations into H1 2028. Looking forward, Absci Corporation (NASDAQ:ABSI) anticipates signing at least one major drug creation partnership with a large pharmaceutical company during 2026.

Absci Corporation (NASDAQ:ABSI) develops several antibody therapeutics.

While we acknowledge the risk and potential of ABSI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ABSI and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.